Author:
Flood Kelsey S.,Porter Martina L.,Kimball Alexa B.
Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference135 articles.
1. Katsanos KH, Christodoulou DK, Tsianos EV. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn’s disease patient. Am J Gastroenterol. 2002;97:2155–6.
2. Van Der Zee HH, Laman JD, De Ruiter L, Dik WA, Prens EP. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. Br J Dermatol. 2012;166(2):298–305.
3. van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol. 2011;164:1292–8.
4. Matusiak Ł, Szczęch J, Bieniek A, Nowicka-Suszko D, Szepietowski JC. Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017;76:670–5.
5. Hurley H. Axillary hyperhidrosis, aprocine bromhidrosis, hidradenitis suppurativa, and familia benign pemphigus: surgical approach. In: Roenigk R, Roenigk H, editors. Dermatologic Surgery Principles and Practice. New York: Marcel Dekker, Inc.; 1989. pp. 729–39.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献